Psoriasin Antibodies

Santa Cruz Biotechnology features a diverse variety of Psoriasin Antibodies for investigating this important protein. Psoriasin Antibodies are suitable for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Psoriasin, also known as S100A7, is a member of the S100 protein family and plays a crucial role in skin homeostasis and immune response. It is primarily expressed in the epidermis and is implicated in the pathogenesis of psoriasis, making it a significant target for understanding skin disorders and inflammatory conditions. The study of Psoriasin is essential for developing therapeutic strategies aimed at treating psoriasis and other related diseases. Psoriasin expression levels serve as valuable indicators in monitoring disease progression and treatment effectiveness. Research has shown that Psoriasin influences various cellular processes, including inflammation, cell proliferation, and differentiation. Understanding Psoriasin's molecular mechanisms can lead to breakthrough discoveries in dermatological treatments. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of Psoriasin and its role in human health.